The Latest Breaking News from FDA

How Pfizer won the pandemic, reaping outsize profit and influence

The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as COVID-19 continues to infect tens of thousands of people and kill hundreds each day.

Tribune News Service · Jul 5, 2022

40 tonnes of drugs to go up in smoke this week

The Food and Drug Administration (FDA) and narcotics suppression authorities on Monday inspected more than 40 tonnes of confiscated illegal drugs worth over 34.6 billion baht before they are incinerated at a designated facility this week.

Bangkok Post · Jul 4, 2022

Parliament an unsafe workplace due to sexual misconduct by MPs, say unions

Political parties cannot be trusted to deal with misbehaviour by their own MPs, claim general secretaries

The Guardian - UK · Jul 4, 2022

US conservatives vow harsh restrictions to curtail abortion pills

Discreet and available by mail, abortion-inducing pills could make conservative abortion bans challenging to enforce.

Al Jazeera · Jul 1, 2022

Updating Coronavirus Vaccines Is Good, But a Universal Coronavirus Vaccine Would Be Better

Time for a new Operation Warp Speed?

Reason · Jul 1, 2022

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jul 1, 2022

FDA Turns Down NRx Pharmaceuticals' Emergency Use Submission For Covid-19 Candidate

The U.S.

Benzinga · Jul 1, 2022

FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants

The FDA's independent experts voted to include a SARS-CoV-2 omicron component in COVID-19 vaccines that would be used for boosters in the U.S. beginning in fall 2022. The panel has advised manufacturers to develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a…

Benzinga · Jul 1, 2022

Review: How Melatonin-Filled 'Lazy Cakes' Became the Subject of a Moral Panic

Senators asked for an investigation since the "sweet, chocolaty taste may encourage consumers to eat well over a recommended quantity of melatonin."

Reason · Jul 1, 2022

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

Benzinga · Jul 1, 2022